Sharon-Lise Normand

Sharon-Lise Normand's AcademicInfluence.com Rankings

Sharon-Lise Normand

Mathematics

#5372

World Rank

#7563

Historical Rank

Statistics

#365

World Rank

#432

Historical Rank

mathematics Degrees

Download Badge

Mathematics

Why Is Sharon-Lise Normand Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Sharon-Lise Teresa Normand is a Canadian biostatistician whose research centers on the evaluation of the quality of care provided by physicians and hospitals, and on the health outcomes for medical devices and medical procedures. She is a professor in the Department of Health Care Policy at the Harvard Medical School and in the Department of Biostatistics at the Harvard T.H. Chan School of Public Health.

(See a Problem?)

Sharon-Lise Normand's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Short screening scales to monitor population prevalences and trends in non-specific psychological distress (2002) (7299)
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. (2014) (1564)
Criteria for Evaluation of Novel Markers of Cardiovascular Risk: A Scientific Statement From the American Heart Association (2009) (1097)
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. (2009) (1079)
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. (2009) (1047)
Meta-analysis: formulating, evaluating, combining, and reporting. (1999) (934)
Use of Cardiac Rehabilitation by Medicare Beneficiaries After Myocardial Infarction or Coronary Bypass Surgery (2007) (785)
National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008. (2011) (662)
Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006. (2010) (661)
Antipsychotic Drug Use and Mortality in Older Adults with Dementia (2007) (591)
Patterns of Hospital Performance in Acute Myocardial Infarction and Heart Failure 30-Day Mortality and Readmission (2009) (561)
An Administrative Claims Measure Suitable for Profiling Hospital Performance on the Basis of 30-Day All-Cause Readmission Rates Among Patients With Heart Failure (2008) (517)
Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding (2005) (507)
An Administrative Claims Model Suitable for Profiling Hospital Performance Based on 30-Day Mortality Rates Among Patients With an Acute Myocardial Infarction (2006) (502)
Cardiac rehabilitation and survival in older coronary patients. (2009) (492)
Statistical Methods for Profiling Providers of Medical Care: Issues and Applications (1997) (467)
Recent National Trends in Readmission Rates After Heart Failure Hospitalization (2010) (455)
ACC/AHA Clinical Performance Measures for Adults with Chronic Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures): endorsed by the Heart Failure Society (2005) (432)
An Administrative Claims Model Suitable for Profiling Hospital Performance Based on 30-Day Mortality Rates Among Patients With Heart Failure (2006) (393)
Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia. (2013) (357)
Coronary Artery Spatial Distribution of Acute Myocardial Infarction Occlusions (2004) (349)
Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada. (1997) (327)
Medical morbidity, mental illness, and substance use disorders. (2002) (324)
Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study (2005) (321)
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3--valve plus coronary artery bypass grafting surgery. (2009) (314)
An Administrative Claims Measure Suitable for Profiling Hospital Performance Based on 30-Day All-Cause Readmission Rates Among Patients With Acute Myocardial Infarction (2011) (314)
Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. (2006) (312)
Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study. (2009) (300)
Cardiac surgery report cards: comprehensive review and statistical critique. (2001) (294)
ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-El (2006) (282)
Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. (2009) (265)
"Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. (2004) (264)
Relation between door-to-balloon times and mortality after primary percutaneous coronary intervention over time: a retrospective study (2015) (263)
Physician clinical performance assessment: prospects and barriers. (2003) (252)
The Revised Behavior and Symptom Identification Scale (BASIS-R): Reliability and Validity (2004) (244)
Hospital volume and 30-day mortality for three common medical conditions. (2010) (241)
Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective. (2012) (239)
Evaluation of a Patient Activation and Empowerment Intervention in Mental Health Care (2008) (237)
Antipsychotic therapy and short-term serious events in older adults with dementia. (2008) (231)
Quality of primary health care in China: challenges and recommendations (2020) (231)
Positive predictive value of the diagnosis of acute myocardial infarction in an administrative database (1999) (228)
Conditioning on the propensity score can result in biased estimation of common measures of treatment effect: a Monte Carlo study (2007) (222)
Quality measurement in adult cardiac surgery: part 1--Conceptual framework and measure selection. (2007) (222)
Quality measurement in adult cardiac surgery: part 2--Statistical considerations in composite measure scoring and provider rating. (2007) (220)
The volume-outcome relationship: from Luft to Leapfrog. (2003) (216)
Variability in the measurement of hospital-wide mortality rates. (2010) (210)
Statistical Issues in Assessing Hospital Performance (2012) (209)
American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care. (2005) (205)
Trends in Hospitalizations and Outcomes for Acute Cardiovascular Disease and Stroke, 1999–2011 (2014) (205)
National Patterns of Risk-Standardized Mortality and Readmission for Acute Myocardial Infarction and Heart Failure: Update on Publicly Reported Outcomes Measures Based on the 2010 Release (2010) (201)
Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis (2006) (191)
New Guidelines for Statistical Reporting in the Journal. (2019) (191)
American College of Cardiology and American Heart Association Methodology for the Selection and Creation of Performance Measures for Quantifying the Quality of Cardiovascular Care (2005) (188)
Comparison of Clinical and Administrative Data Sources for Hospital Coronary Artery Bypass Graft Surgery Report Cards (2007) (181)
Reader's guide to critical appraisal of cohort studies: 1. Role and design (2005) (180)
Behavioral health insurance parity for federal employees. (2006) (179)
Prospective observational studies to assess comparative effectiveness: the ISPOR good research practices task force report. (2012) (177)
ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-El (2006) (175)
TUTORIAL IN BIOSTATISTICS META-ANALYSIS : FORMULATING , EVALUATING , COMBINING , AND REPORTING (1999) (175)
Variations in the Utilization of Coronary Angiography for Elderly Patients with an Acute Myocardial Infarction: An Analysis Using Hierarchical Logistic Regression (1995) (174)
Association of Changing Hospital Readmission Rates With Mortality Rates After Hospital Discharge (2017) (174)
Readers guide to critical appraisal of cohort studies: 3. Analytical strategies to reduce confounding (2005) (172)
Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia: retrospective cohort study (2015) (171)
Statistical and Clinical Aspects of Hospital Outcomes Profiling (2007) (169)
Recent Declines in Hospitalizations for Acute Myocardial Infarction for Medicare Fee-for-Service Beneficiaries: Progress and Continuing Challenges (2010) (168)
Drug-eluting or bare-metal stents for acute myocardial infarction. (2008) (166)
Survival after acute myocardial infarction in patients with end-stage renal disease: results from the cooperative cardiovascular project. (2000) (165)
Measuring performance for treating heart attacks and heart failure: the case for outcomes measurement. (2007) (164)
Rating the appropriateness of coronary angiography--do practicing physicians agree with an expert panel and with each other? (1998) (164)
Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent (2010) (162)
Long-Term Clinical Outcomes After Drug-Eluting and Bare-Metal Stenting in Massachusetts (2008) (157)
Atypical antipsychotics and parkinsonism. (2005) (153)
Development, validation, and results of a measure of 30-day readmission following hospitalization for pneumonia. (2011) (152)
Comparison of “Risk-Adjusted” Hospital Outcomes (2008) (147)
Contemporary Performance of U.S. Teaching and Nonteaching Hospitals (2012) (145)
Comparison of Hospital Risk-Standardized Mortality Rates Calculated by Using In-Hospital and 30-Day Models: An Observational Study With Implications for Hospital Profiling (2012) (143)
Permanent pacemaker selection and subsequent survival in elderly Medicare pacemaker recipients. (1995) (141)
Socioeconomic disparities in outcomes after acute myocardial infarction. (2007) (141)
The Medical Treatment of Depression, 1991-1996: Productive Inefficiency, Expected Outcome Variations, and Price Indexes (2000) (140)
Intent-to-Treat vs. Non-Intent-to-Treat Analyses under Treatment Non-Adherence in Mental Health Randomized Trials. (2008) (140)
Eliciting expert opinion using the Delphi technique: identifying performance indicators for cardiovascular disease. (1998) (140)
Pay for performance in commercial HMOs. (2006) (138)
Public reporting of cardiac surgery performance: Part 1--history, rationale, consequences. (2011) (138)
Trends in the use of drug therapies in patients with acute myocardial infarction: 1988 to 1992. (1994) (136)
ACCF/AHA Clinical Practice Guideline Methodology Summit Report: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (2013) (136)
Outcome of myocardial infarction in Veterans Health Administration patients as compared with medicare patients. (2000) (133)
Mortality, Hospitalizations, and Expenditures for the Medicare Population Aged 65 Years or Older, 1999-2013. (2015) (132)
An Administrative Claims Model for Profiling Hospital 30-Day Mortality Rates for Pneumonia Patients (2011) (131)
Drug-Eluting or Bare-Metal Stenting in Patients With Diabetes Mellitus: Results From the Massachusetts Data Analysis Center Registry (2008) (129)
A Bayesian model for repeated measures zero-inflated count data with application to outpatient psychiatric service use (2010) (126)
Quality of care for the treatment of acute medical conditions in US hospitals. (2006) (126)
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement. (2010) (124)
Meta-Analysis of Rare Binary Adverse Event Data (2012) (116)
Optimal Timing of Intervention in Non–ST-Segment Elevation Acute Coronary Syndromes: Insights From the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Registry (2005) (115)
A prospective study of familial conflict, psychological stress, and the development of substance use disorders in adolescence. (2009) (114)
Regionalization and the underuse of angiography in the Veterans Affairs Health Care System as compared with a fee-for-service system. (2003) (111)
Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention. (2013) (106)
National trends in outcomes among elderly patients with heart failure. (2006) (103)
ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) (103)
Postmarketing surveillance of medical devices--filling in the gaps. (2012) (101)
Analytic Methods for Constructing Cross-Sectional Profiles of Health Care Providers (2000) (101)
Is Same-Hospital Readmission Rate a Good Surrogate for All-Hospital Readmission Rate? (2010) (98)
Getting the methods right--the foundation of patient-centered outcomes research. (2012) (98)
Partial versus full hospitalization for adults in psychiatric distress: a systematic review of the published literature (1957-1997). (2001) (97)
Association of the Hospital Readmissions Reduction Program With Mortality During and After Hospitalization for Acute Myocardial Infarction, Heart Failure, and Pneumonia (2018) (96)
The performance of US hospitals as reflected in risk-standardized 30-day mortality and readmission rates for medicare beneficiaries with pneumonia. (2010) (96)
Managing the care of schizophrenia. Lessons from a 4-year Massachusetts Medicaid study. (1996) (95)
Correlated bivariate continuous and binary outcomes: Issues and applications (2009) (95)
Association of hospital coronary artery bypass volume with processes of care, mortality, morbidity, and the Society of Thoracic Surgeons composite quality score. (2010) (94)
Gaussian models for degradation processes-part I: Methods for the analysis of biomarker data (1995) (92)
Reducing asthma health disparities in poor Puerto Rican children: the effectiveness of a culturally tailored family intervention. (2008) (92)
Measuring and improving quality of care: a report from the American Heart Association/American College of Cardiology First Scientific Forum on Assessment of Healthcare Quality in Cardiovascular Disease and Stroke. (2000) (89)
Public reporting of cardiac surgery performance: Part 2--implementation. (2011) (88)
Massachusetts cardiac surgery report card: implications of statistical methodology. (2005) (88)
Antipsychotic Medications and Drug‐Induced Movement Disorders Other Than Parkinsonism: A Population‐Based Cohort Study in Older Adults (2005) (87)
Warfarin prescribing in atrial fibrillation: the impact of physician, patient, and hospital characteristics. (2006) (86)
Hospital‐Readmission Risk — Isolating Hospital Effects from Patient Effects (2017) (86)
Patient-clinician ethnic concordance and communication in mental health intake visits. (2013) (85)
Differential Item Functioning Between Ethnic Groups in the Epidemiological Assessment of Depression (2008) (84)
Association of Admission to Veterans Affairs Hospitals vs Non-Veterans Affairs Hospitals With Mortality and Readmission Rates Among Older Men Hospitalized With Acute Myocardial Infarction, Heart Failure, or Pneumonia. (2016) (83)
Twenty-Year Trends in Outcomes for Older Adults With Acute Myocardial Infarction in the United States (2019) (83)
ACCF/AHA new insights into the methodology of performance measurement: a report of the American College of Cardiology Foundation/American Heart Association Task Force on performance measures. (2010) (81)
Race, Socioeconomic Status, and Life Expectancy After Acute Myocardial Infarction (2015) (80)
Bayesian Methods Affirm the Use of Percutaneous Coronary Intervention to Improve Survival in Patients With Unprotected Left Main Coronary Artery Disease (2013) (80)
Process of care and outcome after acute myocardial infarction for patients with mental illness in the VA health care system: are there disparities? (2003) (79)
Quality of care for acute myocardial infarction at urban safety-net hospitals. (2007) (79)
Measuring and improving quality of care : A report from the american heart Association/American college of cardiology first scientific forum on assessment of healthcare quality in cardiovascular disease and stroke (2000) (77)
Public reporting of 30-day mortality for patients hospitalized with acute myocardial infarction and heart failure. (2008) (76)
Skilled nursing facility referral and hospital readmission rates after heart failure or myocardial infarction. (2012) (74)
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief report. (2010) (73)
The value of mental health care at the system level: the case of treating depression. (1999) (72)
Performance Measurement in the Small Office Practice: Challenges and Potential Solutions (2008) (71)
A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases (2011) (71)
A framework for evidence evaluation and methodological issues in implantable device studies. (2010) (68)
Assessing incentives for service-level selection in private health insurance exchanges. (2014) (67)
Predicting the Restenosis Benefit of Drug-Eluting Versus Bare Metal Stents in Percutaneous Coronary Intervention (2011) (66)
Characteristics and Outcomes of Patients Receiving New and Replacement Implantable Cardioverter-Defibrillators: Results From the NCDR (2013) (65)
Accounting For Patients' Socioeconomic Status Does Not Change Hospital Readmission Rates. (2016) (65)
Automated surveillance to detect postprocedure safety signals of approved cardiovascular devices. (2010) (65)
How missing information in diagnosis can lead to disparities in the clinical encounter. (2008) (65)
Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practice. (2012) (63)
Variation in hospital mortality rates for patients with acute myocardial infarction. (2010) (63)
Use of Machine Learning Models to Predict Death After Acute Myocardial Infarction. (2021) (63)
The Society of Thoracic Surgeons Composite Measure of Individual Surgeon Performance for Adult Cardiac Surgery: A Report of The Society of Thoracic Surgeons Quality Measurement Task Force. (2015) (61)
Quality of care in Medicaid managed care and commercial health plans. (2007) (61)
Impact of Underuse, Overuse, and Discretionary Use on Geographic Variation in the Use of Coronary Angiography After Acute Myocardial Infarction (2001) (60)
Comparative assessment of implantable hip devices with different bearing surfaces: systematic appraisal of evidence (2011) (60)
A Prediction Model to Identify Patients at High Risk for 30-Day Readmission After Percutaneous Coronary Intervention (2013) (60)
Geographic variation of procedure utilization. A hierarchical model approach. (1993) (59)
Comparative Effectiveness of ST-Segment–Elevation Myocardial Infarction Regionalization Strategies (2010) (58)
Guideline recommendations for treatment of schizophrenia: the impact of managed care. (2003) (58)
Gender differences in the association between family conflict and adolescent substance use disorders. (2011) (57)
Standards for Measures Used for Public Reporting of Efficiency in Health Care: A Scientific Statement From the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research and the American College of Cardiology Foundation (2008) (57)
Improvement in mortality risk prediction after percutaneous coronary intervention through the addition of a "compassionate use" variable to the National Cardiovascular Data Registry CathPCI dataset: a study from the Massachusetts Angioplasty Registry. (2011) (57)
Nonemergency PCI at hospitals with or without on-site cardiac surgery. (2013) (56)
Sources of Hospital Variation in Short-Term Readmission Rates After Percutaneous Coronary Intervention (2012) (55)
ACCF/AHA New Insights Into the Methodology of Performance Measurement: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (2010) (53)
Based on key measures, care quality for Medicare enrollees at safety-net and non-safety-net hospitals was almost equal. (2012) (53)
Development and validation of a claims based index for adjusting for risk of mortality: the case of acute myocardial infarction. (1995) (53)
Comparison of Use of Medications After Acute Myocardial Infarction in the Veterans Health Administration and Medicare (2001) (52)
Registry‐Based Prospective, Active Surveillance of Medical‐Device Safety (2017) (51)
Elapsed Time in Emergency Medical Services for Patients With Cardiac Complaints: Are Some Patients at Greater Risk for Delay? (2009) (51)
Association Between the Amount of Vaginal Mesh Used With Mesh Erosions and Repeated Surgery After Repairing Pelvic Organ Prolapse and Stress Urinary Incontinence (2016) (51)
"America's Best Hospitals" in the treatment of acute myocardial infarction. (2007) (51)
Use of Remote Monitoring Is Associated With Lower Risk of Adverse Outcomes Among Patients With Implanted Cardiac Defibrillators (2015) (51)
Does prospective payment reduce inpatient length of stay? (2002) (50)
The comprehensive care project: measuring physician performance in ambulatory practice. (2010) (50)
Bridging Unmet Medical Device Ecosystem Needs With Strategically Coordinated Registries Networks. (2015) (49)
A Bayesian Two‐Part Latent Class Model for Longitudinal Medical Expenditure Data: Assessing the Impact of Mental Health and Substance Abuse Parity (2011) (49)
Patient Activity and Survival Following Implantable Cardioverter-Defibrillator Implantation: The ALTITUDE Activity Study (2015) (48)
Standards for measures used for public reporting of efficiency in health care: a scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes research and the American College of Cardiology Foundation. (2008) (48)
Understanding Individual and Small Area Variation in the Underuse of Coronary Angiography Following Acute Myocardial Infarction (2002) (47)
Causes of Short-Term Readmission After Percutaneous Coronary Intervention (2014) (47)
Impact of Full Mental Health and Substance Abuse Parity for Children in the Federal Employees Health Benefits Program (2007) (46)
Using Non-experimental Data to Estimate Treatment Effects. (2009) (46)
Risk of weight gain for specific antipsychotic drugs: a meta-analysis (2018) (46)
Longitudinal profiling of health care units based on continuous and discrete patient outcomes. (2005) (45)
Mortality risk following replacement implantable cardioverter-defibrillator implantation at end of battery life: results from the NCDR. (2014) (45)
Employers' use of value-based purchasing strategies. (2007) (45)
Externally caused deaths for adults with substance use and mental disorders (2005) (44)
Longitudinal profiles of health care providers (2002) (44)
Improving quality and diffusing best practices: the case of schizophrenia. (2009) (44)
Vascular closure device failure in contemporary practice. (2012) (44)
Integrating risk adjustment and enrollee premiums in health plan payment. (2013) (44)
Geographic Disparities in the Incidence and Outcomes of Hospitalized Myocardial Infarction: Does a Rising Tide Lift All Boats? (2012) (44)
Life Expectancy after Myocardial Infarction, According to Hospital Performance. (2016) (43)
Early Results of Massachusetts Healthcare Reform on Racial, Ethnic, and Socioeconomic Disparities in Cardiovascular Care (2014) (42)
Risk Factors Associated With Major Cardiovascular Events 1 Year After Acute Myocardial Infarction (2018) (41)
Parameter Updating in a Bayes Network (1992) (40)
A comparison of methods for combining quality and efficiency performance measures: Profiling the value of hospital care following acute myocardial infarction (2008) (40)
Applying Bayesian ideas to the development of medical guidelines. (1999) (40)
The effects of mental health parity on spending and utilization for bipolar, major depression, and adjustment disorders. (2013) (40)
Computer-modeling and Graphical Strategies for Meta-analysis (2000) (40)
The use and abuse of multiple outcomes in randomized controlled depression trials. (2011) (39)
The Impact of Parity on Major Depression Treatment Quality in the Federal Employees’ Health Benefits Program After Parity Implementation (2006) (39)
Assessing surrogacy of data sources for institutional comparisons (2007) (38)
Ten-year trends in quality of care and spending for depression: 1996 through 2005. (2011) (38)
Association of Racial and Socioeconomic Disparities With Outcomes Among Patients Hospitalized With Acute Myocardial Infarction, Heart Failure, and Pneumonia (2018) (38)
Population trends in rates of coronary revascularization. (2015) (38)
Some Old and Some New Statistical Tools for Outcomes Research (2008) (38)
The RECOVERY Platform (2020) (37)
Evaluating the optimal timing of angiography: landmark or off the mark? (2007) (37)
Hospital-wide Mortality as a Quality Metric (2012) (36)
Hospital Teaching Intensity and Mortality for Acute Myocardial Infarction, Heart Failure, and Pneumonia (2014) (36)
Assessing the Accuracy of Hospital Clinical Performance Measures (2007) (35)
Acute Myocardial Infarction and Congestive Heart Failure Outcomes at Specialty Cardiac Hospitals (2007) (35)
Older Men with Dementia Are at Greater Risk than Women of Serious Events After Initiating Antipsychotic Therapy (2013) (35)
"Usual care" for major depression in the 1990s: characteristics and expert-estimated outcomes. (2003) (35)
Clinical Preventability of 30‐Day Readmission After Percutaneous Coronary Intervention (2014) (34)
Incentive formularies and changes in prescription drug spending. (2007) (34)
A meta-analysis of labor supply effects of interventions for major depressive disorder. (2006) (34)
Statistical methodology for classifying units on the basis of multiple‐related measures (2008) (34)
Implementation of a cardiac surgery report card: lessons from the Massachusetts experience. (2005) (34)
The National Cardiovascular Data Registry Voluntary Public Reporting Program: An Interim Report From the NCDR Public Reporting Advisory Group. (2016) (33)
Managed care and children's behavioral health services in Massachusetts. (2001) (33)
What is a performance outlier? (2015) (33)
Application of models for multivariate mixed outcomes to medical device trials: coronary artery stenting (2002) (33)
Mortality and Readmission for Patients With Heart Failure Among U.S. News & World Report’s Top Heart Hospitals (2009) (32)
Likelihood Methods for Treatment Noncompliance and Subsequent Nonresponse in Randomized Trials (2005) (32)
Bivalirudin Therapy Is Associated With Improved Clinical and Economic Outcomes in ST-Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention: Results From an Observational Database (2012) (31)
Regional Density of Cardiologists and Rates of Mortality for Acute Myocardial Infarction and Heart Failure (2013) (31)
Kessler Psychological Distress Scale (K10) (2012) (31)
Estimating cost-offsets of new medications: Use of new antipsychotics and mental health costs for schizophrenia (2011) (31)
On determination of sample size in hierarchical binomial models (2001) (31)
Coronary Artery Bypass Graft: Contemporary Heart Surgery Center Performance in China (2012) (31)
Hospital patterns of use of positive inotropic agents in patients with heart failure. (2012) (31)
Meta-Analysis Software: A Comparative Review (1995) (30)
Association Between Medication Adherence and 1‐Year Major Cardiovascular Adverse Events After Acute Myocardial Infarction in China (2019) (30)
Life Expectancy and Years of Potential Life Lost After Acute Myocardial Infarction by Sex and Race: A Cohort-Based Study of Medicare Beneficiaries. (2015) (30)
Effects of treatment recommendations and specialist intervention on care provided by primary care physicians to patients with myocardial infarction or heart failure. (2004) (30)
Differences in patient survival after acute myocardial infarction by hospital capability of performing percutaneous coronary intervention: implications for regionalization. (2010) (30)
Low-volume coronary artery bypass surgery: measuring and optimizing performance. (2008) (30)
Comparing Teaching Versus Nonteaching Hospitals: The Association of Patient Characteristics With Teaching Intensity for Three Common Medical Conditions (2014) (30)
Massachusetts Medicaid managed health care reform: treatment for the psychiatrically disabled. (1995) (30)
Associations Between Adherence to Guidelines for Antipsychotic Dose and Health Status, Side Effects, and Patient Care Experiences (2006) (29)
Hospice Use Following Implantable Cardioverter-Defibrillator Implantation in Older Patients (2016) (29)
Developing an African youth psychosocial assessment: an application of item response theory (2014) (29)
Postmarket surveillance for medical devices: America’s new strategy (2012) (29)
Quality of care in the US territories. (2011) (28)
Disparities in quality of care among publicly insured adults with schizophrenia in four large U.S. states, 2002-2008. (2014) (28)
Long-term clinical outcomes following drug-eluting or bare-metal stent placement in patients with severely reduced GFR: Results of the Massachusetts Data Analysis Center (Mass-DAC) State Registry. (2011) (27)
Impact of Independent Data Adjudication on Hospital-Specific Estimates of Risk-Adjusted Mortality Following Percutaneous Coronary Interventions in Massachusetts (2011) (27)
Enhancing the Prediction of 30-Day Readmission After Percutaneous Coronary Intervention Using Data Extracted by Querying of the Electronic Health Record (2015) (26)
Statistical Approaches to Modeling Multiple Outcomes In Psychiatric Studies. (2009) (26)
Hospital variation in carotid stenting outcomes. (2015) (26)
Comparison of Self-report and Clinician-rated Measures of Psychiatric Symptoms and Functioning in Predicting 1-year Hospital Readmission (2006) (26)
Effects of gender and ethnicity on outcomes after aortic valve replacement. (2012) (25)
Comparing Outcomes of Coronary Artery Bypass Grafting Among Large Teaching and Urban Hospitals in China and the United States (2017) (25)
On the use of discrete choice models for causal inference (2005) (25)
Selection of Related Multivariate Means (2003) (24)
Effect of insurance parity on substance abuse treatment. (2011) (24)
A geospatial analysis of emergency transport and inter-hospital transfer in ST-segment elevation myocardial infarction. (2008) (24)
Balancing Treatment Comparisons in Longitudinal Studies. (2008) (23)
Health Policy Trials. (2017) (23)
Medication use and spending trends among children with ADHD in Florida's Medicaid program, 1996-2005. (2012) (22)
Thirty-Day Outcomes in Medicare Patients With Heart Failure at Heart Transplant Centers (2010) (22)
Ten-Year Trends in Quality of Care and Spending for Depression (2016) (22)
Sample Size Determination for Studies with Repeated Continuous Outcomes. (2008) (22)
Clinical and analytical considerations in the study of health status in device trials for heart failure. (2005) (22)
Hospital remoteness and thirty-day mortality from three serious conditions. (2008) (22)
Alternative methods for testing treatment effects on the basis of multiple outcomes: Simulation and case study (2011) (22)
League Tables for Hospital Comparisons (2016) (22)
The Relationship Between Medical Practice Characteristics and Quality of Care for Cardiovascular Disease (2008) (22)
Managed mental health experience in Massachusetts. (1998) (21)
Rating the Raters: The Inconsistent Quality of Health Care Performance Measurement (2016) (21)
The effect of race-ethnicity on the comparative effectiveness of clozapine among Medicaid beneficiaries. (2013) (21)
Post-Acute Service Use Following Acute MyocardialInfarction in the Elderly (2002) (21)
The Data Extraction and Longitudinal Trend Analysis Network Study of Distributed Automated Postmarket Cardiovascular Device Safety Surveillance (2015) (21)
Longitudinal Racial/Ethnic Disparities in Antimanic Medication Use in Bipolar-I Disorder (2009) (21)
Improving traditional intention-to-treat analyses: a new approach (2005) (20)
Pitfalls in assessing the quality of care for patients with cardiovascular disease. (2001) (20)
Use of Administrative Claims Models to Assess 30-Day Mortality Among Veterans Health Administration Hospitals (2010) (20)
Modeling Mortality Rates for Elderly Heart Attack Patients: Profiling Hospitals in the Cooperative Cardiovascular Project (1997) (20)
Evaluating the Generalizability of a Large Streamlined Cardiovascular Trial: Comparing Hospitals and Patients in the Dual Antiplatelet Therapy Study Versus the National Cardiovascular Data Registry (2015) (20)
A maximum likelihood approach to power calculations for stepped wedge designs of binary outcomes. (2018) (19)
Comparison of Inappropriate Shocks and Other Health Outcomes Between Single‐ and Dual‐Chamber Implantable Cardioverter‐Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter‐Defibrillators (2017) (19)
Evaluation of an automated safety surveillance system using risk adjusted sequential probability ratio testing (2011) (19)
Selection and Plan Switching Behavior (2005) (19)
Assessment of Between-Hospital Variation in Readmission and Mortality After Cancer Surgical Procedures (2018) (19)
Investigation of racial and ethnic disparities in service utilization among homeless adults with severe mental illnesses. (2009) (18)
Comparison of Hospital Risk-Standardized Mortality Rates using In-hospital and 30-Day Models: Implications for Hospital Profiling (2012) (18)
Comparison of prescribing practices for older adults treated by female versus male physicians: A retrospective cohort study (2018) (18)
Crowd-out and exposure effects of physical comorbidities on mental health care use: implications for racial-ethnic disparities in access. (2011) (17)
Designs for mechanical circulatory support device studies. (2007) (17)
Declining Admission Rates And Thirty-Day Readmission Rates Positively Associated Even Though Patients Grew Sicker Over Time. (2016) (17)
Protocol for the China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) retrospective study of coronary catheterisation and percutaneous coronary intervention (2014) (17)
Discriminating Quality of Hospital Care in the United States (2008) (17)
Parity and Out-of-Pocket Spending for Children With High Mental Health or Substance Abuse Expenditures (2013) (17)
Use of a state inpatient forensic system under managed mental health care. (2002) (16)
Racial and ethnic disparities in access to higher and lower quality cardiac surgeons for coronary artery bypass grafting. (2009) (16)
Rethinking Analytical Strategies for Surveillance of Medical Devices: The Case of Hip Arthroplasty (2010) (16)
Transfer rates from nonprocedure hospitals after initial admission and outcomes among elderly patients with acute myocardial infarction. (2014) (16)
Using Elicitation Techniques to Estimate the Value of Ambulatory Treatments for Major Depression (2002) (16)
Where You Live Matters: Quality and Racial/Ethnic Disparities in Schizophrenia Care in Four State Medicaid Programs. (2015) (16)
Comparative Effectiveness of New Approaches to Improve Mortality Risk Models From Medicare Claims Data (2019) (15)
Geographic and Temporal Variation in Cardiac Implanted Electric Devices to Treat Heart Failure (2016) (15)
SAMPLE SIZE CALCULATION FOR A HISTORICALLY CONTROLLED CLINICAL TRIAL WITH ADJUSTMENT FOR COVARIATES (2002) (15)
Understanding variability in physician ratings of the appropriateness of coronary angiography after acute myocardial infarction. (1999) (15)
Study protocol for a cluster randomised controlled trial to assess the effectiveness of user-driven intervention to prevent aggressive events in psychiatric services (2017) (15)
Antidepressant reformulations: who uses them, and what are the benefits? (2009) (15)
Quality monitoring and management in commercial health plans. (2008) (15)
Geographic Variation of Procedure Utilization (1993) (14)
Real Output in Mental Health Care during the 1990s (2005) (14)
Patterns of Antipsychotic Prescribing by Physicians to Young Children. (2016) (14)
Engagement of Health Plans and Employers in Addressing Racial and Ethnic Disparities in Health Care (2009) (14)
Association of Guideline-Based Admission Treatments and Life Expectancy After Myocardial Infarction in Elderly Medicare Beneficiaries. (2016) (14)
Trends in the use of coercive measures in Finnish psychiatric hospitals: a register analysis of the past two decades (2019) (14)
Assessing the cost burden of United States FDA-mandated post-approval studies for medical devices. (2016) (13)
Characteristics of medical practices in three developed managed care markets. (2005) (13)
[Bayesian Analysis in Expert Systems]: Comment (1993) (13)
A Cost-Effectiveness Framework for Profiling the Value of Hospital Care (2008) (13)
Instrumental Variable Analysis to Compare Effectiveness of Stents in the Extremely Elderly (2014) (13)
Mandatory public reporting of cardiac surgery outcomes: The 2003 to 2014 Massachusetts experience. (2019) (13)
Association Between Hospital Performance on Patient Safety and 30‐Day Mortality and Unplanned Readmission for Medicare Fee‐for‐Service Patients With Acute Myocardial Infarction (2016) (13)
Bayesian propensity scores for high‐dimensional causal inference: A comparison of drug‐eluting to bare‐metal coronary stents (2017) (13)
Identifying Medicare beneficiaries with dementia (2021) (12)
Studies of Drug-Eluting Stents: To Each His Own? (2008) (12)
Measuring hospital clinical outcomes (2013) (12)
Meta‐analysis of rate ratios with differential follow‐up by treatment arm: inferring comparative effectiveness of medical devices (2015) (12)
Prescribing of Clozapine and Antipsychotic Polypharmacy for Schizophrenia in a Large Medicaid Program. (2017) (12)
Initial Cholinesterase Inhibitor Therapy Dose and Serious Events in Older Women and Men (2018) (12)
Assessment of Second-Generation Diabetes Medication Initiation Among Medicare Enrollees From 2007 to 2015 (2020) (11)
Using Multiple Control Groups and Matching to Address Unobserved Biases in Comparative Effectiveness Research (2011) (11)
Double robust estimation for multiple unordered treatments and clustered observations: Evaluating drug‐eluting coronary artery stents (2018) (11)
The relation of telomere length at midlife to subsequent 20‐year depression trajectories among women (2019) (11)
Geographical Health Priority Areas For Older Americans. (2018) (11)
"Phenotyping" hospital value of care for patients with heart failure. (2014) (11)
Thirty-Day Hospital Readmission for Medicaid Enrollees with Schizophrenia: The Role of Local Health Care Systems. (2015) (10)
Approaches to treatment effect heterogeneity in the presence of confounding (2019) (10)
Mitigating the Problem of Unmeasured Outcomes in Quality Reports (2008) (10)
Racial and ethnic service use disparities among homeless adults with severe mental illnesses receiving ACT. (2011) (10)
Integrating Statistical and Clinical Research Elements in Intervention-Related Grant Applications: Summary From an NIMH Workshop (2009) (10)
Measuring percutaneous coronary intervention quality by simple case volume. (2005) (10)
Can machine learning complement traditional medical device surveillance? A case study of dual-chamber implantable cardioverter–defibrillators (2017) (10)
Abstract 16550: Physician Annual Volume and In-Hospital Mortality Following Percutaneous Coronary Intervention (2011) (10)
Guideline Recommendations for Treatment of Schizophrenia (2003) (9)
Diffusion of Bevacizumab Across Oncology Practices: An Observational Study (2018) (9)
Meta-Analysis Software: A Comparative Review@@@DSTAT, Version 1.10@@@TRUE EPISTAT, Version 4.0@@@FAST*PRO, Version 1.0 (1995) (9)
Impact of cardiac service availability on case-selection for angiography and survival associated with angiography. (2003) (9)
The Atlantic divide in coronary heart disease: Epidemiology and patient care in the US and Portugal. (2017) (9)
Models for Degradation Processes and Event Times Based on Gaussian Processes (1996) (9)
The effect of race-ethnicity and geography on adoption of innovations in the treatment of schizophrenia. (2012) (9)
Evidence of a gabapentinoid and diuretic prescribing cascade among older adults with lower back pain (2021) (9)
Facility-Level Variation and Clinical Outcomes in Use of Cardiac Resynchronization Therapy With and Without an Implantable Cardioverter-Defibrillator (2018) (9)
Association Between Subsequent Hospitalizations and Recurrent Acute Myocardial Infarction Within 1 Year After Acute Myocardial Infarction (2020) (9)
Determining the Minimum Sample Size of Audit Data Required to Profile User Behavior and Detect Anomaly Intrusion (2006) (9)
Drug‐eluting stents versus bare metal stents prior to noncardiac surgery (2015) (8)
Bipolar-I patient characteristics associated with differences in antimanic medication prescribing. (2009) (8)
Autonomy, beneficence, justice, and the limits of provider profiling. (2012) (8)
Special Applications of Pharmacoepidemiology (2013) (8)
Evaluating Readmission-Need for More Clarity on Methods. (2018) (8)
Rating the Raters (2016) (8)
studies: 1. Role and design Reader's guide to critical appraisal of cohort (2005) (8)
Cost-Offsets of New Medications for Treatment of Schizophrenia (2006) (8)
Composite measures for hospital quality using quality‐adjusted life years (2009) (8)
The Role of ANCOVA in Analyzing Experimental Data (2009) (8)
Matching and Imputation Methods for Risk Adjustment in the Health Insurance Marketplaces (2017) (8)
Claims-based cardiovascular outcome identification for clinical research: Results from 7 large randomized cardiovascular clinical trials. (2019) (8)
Determining value of Coordinated Registry Networks (CRNs): a case of transcatheter valve therapies (2019) (8)
Accurately Predicting Bipolar Disorder Mood Outcomes: Implications for the use of Electronic Databases (2012) (7)
Toward a model for testing the relationship between quality of care and costs. (2004) (7)
Rationale and Design of the Women and Inclusion in Academic Medicine Study. (2016) (7)
Managed mental health care's effects on arrest and forensic commitment. (2004) (7)
Outpatient care for opioid use disorder among the commercially insured: Use of medication and psychosocial treatment. (2020) (7)
Designing, Conducting, Monitoring, and Analyzing Data from Pragmatic Randomized Clinical Trials: Proceedings from a Multi-stakeholder Think Tank Meeting (2020) (7)
Antipsychotic Prescribing: Do Conflict of Interest Policies Make a Difference? (2015) (7)
Regional Variation in Physician Adoption of Antipsychotics: Impact on US Medicare Expenditures. (2016) (7)
LETTER TO THE EDITOR Conditioning on the propensity score can result in biased estimation of common measures of treatment effect: A Monte Carlo study (p n/a) (2007) (7)
Safety Culture and Mortality after Acute Myocardial Infarction: A Study of Medicare Beneficiaries at 171 Hospitals (2018) (7)
Economic grand rounds: the price is right? Changes in the quantity of services used and prices paid in response to parity. (2012) (7)
Association Between Medicare Expenditures and Adverse Events for Patients With Acute Myocardial Infarction, Heart Failure, or Pneumonia in the United States (2020) (6)
Medication Utilization for Alcohol Use Disorder in a Commercially Insured Population (2020) (6)
Cancer Rates in Adults After Cardiac Interventions: A Preliminary Observational Report (2017) (6)
Reader's guide to critical appraisal of cohort studies: 1. Role and design (2005) (6)
Practice variation and length of stay in alcohol and drug detoxification centers. (2005) (6)
Assessing geographical variations in hospital processes of care using multilevel item response models (2010) (6)
Effect of Insurance Parity on Substance Abuse Treatment (2011) (6)
Identifying a Cohort of Patients With Early-Stage Breast Cancer: A Comparison of Hospital Discharge and Primary Data (2001) (5)
Nonparametric Bayesian Instrumental Variable Analysis: Evaluating Heterogeneous Effects of Coronary Arterial Access Site Strategies (2018) (5)
Cardiology patient pages. How are our hospitals measuring up?: "hospital compare": a resource for hospital quality of care. (2008) (5)
Relationship of Hospital Performance with Readmission and Mortality Rates for Patients Hospitalized with Acute Myocardial Infarction , Heart Failure , or Pneumonia (2013) (5)
Socioeconomic Background and Commercial Health Plan Spending (2017) (5)
Association of Hospital Payment Profiles With Variation in 30-Day Medicare Cost for Inpatients With Heart Failure or Pneumonia (2019) (5)
Surgeons: Buyer beware-does "universal" risk prediction model apply to patients universally? (2020) (5)
What is evidence? (2010) (5)
Comparative effectiveness research: does one size fit all? (2012) (5)
Likelihood-Based Random-Effect Meta-Analysis of Binary Events (2015) (5)
A comparison of in-hospital acute myocardial infarction management between Portugal and the United States: 2000–2010 (2014) (5)
Computer Modeling Strategies for Meta-analysis (2007) (4)
Limiting Inpatient Substance Use Treatment: What are the Consequences? (2003) (4)
Mortality and Readmission at Safety Net and Non-Safety Net Hospitals for Three Common Medical Conditions (2012) (4)
Challenges in the Use of Administrative Data for Heart Failure Services Research. (2016) (4)
Epidemiologic Studies of Medical Devices: Methodologic Considerations for Implantable Devices (2012) (4)
Handling incomplete correlated continuous and binary outcomes in meta‐analysis of individual participant data (2016) (4)
An Overview of Statistical Approaches for Comparative Effectiveness Research (2017) (4)
When less is more: using shrinkage to increase accuracy. (2010) (4)
MISSING DATA IN REGRESSION MODELS FOR NON-COMMENSURATE MULTIPLE OUTCOMES. (2011) (4)
Hospital Phenotypes in the Management of Patients Admitted for Acute Myocardial Infarction (2016) (4)
Outcome‐dependent sampling in cluster‐correlated data settings with application to hospital profiling (2019) (4)
Hospital Performance Assessment in Congenital Heart Surgery - Where Do We Go from Here? (2020) (4)
Graded response model-based item selection for behavior and symptom identification (2006) (3)
Abstract 26: Comparison of Medicare Claims with Clinical Trial Outcomes for Follow-up of Older Individuals with Acute Coronary Syndrome (2014) (3)
Machine-learning to Improve Prediction of Mortality following Acute Myocardial Infarction: An Assessment in the NCDR-Chest Pain-Myocardial Infarction Registry (2019) (3)
The Derivation of a Latent ThresholdInstrumental Variables (1995) (3)
Isolating Effects of Medicare Code Slot Expansion on Longitudinal Risk Assessment (2019) (3)
Regional Associations Between Medicare Advantage Penetration and Administrative Claims-based Measures of Hospital Outcomes (2012) (3)
Picturing inequities for health impact assessment: linked electronic records, mortality and regional disparities in Portugal (2018) (3)
Health and Health Insurance: Analysis of Plan Switching Behavior (2005) (3)
Evaluating selection out of health plans for medicaid beneficiaries with substance abuse (2005) (3)
Rationale and design of the MASS COMM trial: A randomized trial to compare percutaneous coronary intervention between MASSachusetts hospitals with cardiac surgery on-site and COMMunity hospitals without cardiac surgery on-site. (2011) (3)
Development and Testing of Improved Models to Predict Payment Using Centers for Medicare & Medicaid Services Claims Data (2019) (3)
Attribution of Adverse Events Following Coronary Stent Placement Identified Using Administrative Claims Data (2020) (3)
STEEP DECLINES IN POPULATION RATES OF CORONARY REVASCULARIZATION (2014) (3)
Comparative Safety of Aspiration Thrombectomy Catheters Utilizing Prospective, Active Surveillance of the NCDR CathPCI Registry (2019) (3)
Revised Behavior and Symptom Identification Scale (2019) (3)
Hierarchical Models in Health Services Research (2022) (3)
Quality of Care in the United States Territories, 1999–2012 (2017) (2)
Helping decision-makers visualize inequities in health impact assessment : linked electronic records, mortality and regional disparities in Portugal (2016) (2)
All-Cause Mortality and Progression to End-Stage Kidney Disease Following Percutaneous Revascularization or Surgical Coronary Revascularization in Patients with CKD (2021) (2)
Registry studies for improving the quality of cardiovascular care: the role of variance components. (2012) (2)
Missing data and convenient assumptions. (2010) (2)
The association of hospital teaching intensity with 30-day postdischarge heart failure readmission and mortality rates. (2020) (2)
Regulator Loss Functions and Hierarchical Modeling for Safety Decision Making (2017) (2)
Where You Live Matters (2015) (2)
DEVELOPMENT OF TWO REGISTRY-BASED MEASURES SUITABLE FOR CHARACTERIZING HOSPITAL PERFORMANCE ON 30-DAY ALL-CAUSE MORTALITY RATES AMONG PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2010) (2)
Myocardial infarction and quality of care (2008) (2)
Nursing Home Use After Implantable Cardioverter‐Defibrillator Implantation in Older Adults: Results from the National Cardiovascular Data Registry (2017) (2)
Discussion on “Time‐dynamic profiling with application to hospital readmission among patients on dialysis,” by Jason P. Estes, Danh V. Nguyen, Yanjun Chen, Lorien S. Dalrymple, Connie M. Rhee, Kamyar Kalantar‐Zadeh, and Damla Senturk (2018) (2)
Mortality Prediction Following Cardiac Surgery in Children - An STS Congenital Heart Surgery Database Analysis. (2022) (2)
Bayesian Meta-analysis of Multiple Continuous Treatments with Individual Participant-Level Data: An Application to Antipsychotic Drugs (2019) (2)
Frequency of the use of low- versus high-dose aspirin in dual antiplatelet therapy after percutaneous coronary intervention (from the Dual Antiplatelet Therapy study). (2014) (2)
Abstract 18716: 30-Day All-Cause Readmission After Percutaneous Coronary Intervention in Massachusetts: Clinical Predictors and Hospital-Variation of a New Quality Metric (2010) (2)
Evaluating The Accuracy Of Medicare Risk Adjustment For Alzheimer's Disease And Related Dementias. (2022) (2)
Simulated Effects of Policies to Reduce Diabetes Risk Among Adults With Schizophrenia Receiving Antipsychotics. (2017) (2)
Evaluation of Lifestyle Modification and Cardiac Rehabilitation in Medicare Beneficiaries* Use of Cardiac Rehabilitation by Medicare Beneficiaries after Myocardial Infarction or Coronary Bypass Surgery + (2009) (2)
Abstract 4499: Outcomes Following Primary Percutaneous Coronary Intervention: A Comparison Between Hospitals With and Without Cardiac Surgery On-Site (2009) (2)
Quality of Care (2005) (1)
SELECTIVE DRUG-ELUTING STENT USE IN ELDERLY PATIENTS: IMPACT ON PERCUTANEOUS CORONARY INTERVENTION MORTALITY AND BLEEDING RISK (2012) (1)
83. Network Meta-Analysis of Causal Dose-Response Relationships Using Individual Participant Trial Data (2017) (1)
Likelihood Modelling: Meta‐Analysis: Formulating, Evaluating, Combining, and Reporting (2005) (1)
PCI at hospitals with or without on-site cardiac surgery. (2013) (1)
Response to Letter from Dr. Alexander S. Young (2007) (1)
Quality of Care in the United States Territories, 1999-2012. (2017) (1)
P115 Software for exploration and modeling of meta-analyses (1997) (1)
Behavioral Health Parity (2007) (1)
INDEPENDENT US VALIDATION OF THE BRITISH COLUMBIA PCI RISK SCORE (2010) (1)
HFSA Working Group Designs for Mechanical Circulatory Support Device Studies (2007) (1)
retrospective cohort study ischaemic stroke: population based Atypical antipsychotic drugs and risk of (2006) (1)
Thirty-day hospital re-admission for Medicaid enrollees with schizophrenia: the role of patient comorbidity and local health-care systems (2015) (1)
Significance and Factors Associated with Antipsychotic Polypharmacy Utilization Among Publicly Insured US Adults (2021) (1)
Abstract 3999: The Impact of Race and Insurance Status on Utilization Rates and Outcomes after Coronary Artery Bypass Grafting Surgery in the Commonwealth of Massachusetts (2006) (1)
THE LEARNING CURVE FOR MEDICAL DEVICES: EXPERIENCE WITH VASCULAR CLOSURE DEVICES IN MASSACHUSETTS (2013) (1)
Statement From the American Heart Association Criteria for Evaluation of Novel Markers of Cardiovascular Risk. A Scientific (2009) (1)
Utilization of diagnostic tests: Assessing appropriateness (1999) (1)
HSOR Special Issue on Causal Inference: Introduction (2001) (1)
Standards for Measures Used for Public Reporting of Efﬁciency in Health Care (2008) (1)
Hospital-Readmission Risk - Isolating Hospital Effects. (2017) (1)
Abstract 136: The Relationship of Changing Hospital Readmission Rates and Mortality Rates After Hospitalization for Heart Failure, Acute Myocardial Infarction, and Pneumonia (2017) (1)
NEJM Evidence — A New Journal in the NEJM Group Family (2022) (1)
Using Multiple Comparison Groups to Address Unobserved Biases in Comparative Effectiveness Research (2011) (0)
Bayesian Meta-Analysis of Multiple Continuous Treatments: An Application to Antipsychotic Drugs (2018) (0)
Association Between Hospital Performance on Patient Safety and 30Day Mortality and Unplanned Readmission for Medicare FeeforService Patients With Acute Myocardial Infarction (2016) (0)
Abstract 1848: Coronary Artery Bypass Grafting after Uneventful Percutaneous Coronary Intervention in the Commonwealth of Massachusetts (2007) (0)
Abstract 14469: Optimal Use of Drug-Eluting Stents in PCI: Implications of Healthcare Policy in Real-World Practice (2011) (0)
Atypical antipschotic drugs and risk of ischemic storke: population based retrospective cohort study (2005) (0)
Empirical Bayes Procedures for a Change Point Problem with Application to HIV/AIDS Data (2001) (0)
Nonparametric Bayesian Instrumental Variable Analysis: Evaluating Heterogeneous Effects of Arterial Access Sites for Opening Blocked Blood Vessels (2018) (0)
Re-evaluating Congenital Heart Surgery Center Performance Using Operative Mortality. (2022) (0)
Comparative effectiveness of cardiac implantable electrical devices (2015) (0)
Abstract 18556: Trends in Door-to-Balloon Time and Mortality in STEMI Patients Undergoing Primary PCI in Massachusetts (2012) (0)
Multi-Dimensional Item Response Theory Models for Estimating Racial/Ethnic Health Care Quality Disparities (2023) (0)
Performance of a novel risk model for deep sternal wound infection after coronary artery bypass grafting (2021) (0)
Abstract 321: A Validated Model to Identify Patients at High Risk for 30-Day Readmission After Percutaneous Coronary Intervention (2012) (0)
GENDER-SPECIFIC PATHWAYS FROM FAMILY CONFLICT IN CHILDHOOD TO ADOLESCENT ALCOHOL OR MARIJUANA USE DISORDERS (2010) (0)
Not Sold on Performance Measures. Authors' reply (2008) (0)
Medical Simulation : Tools for Learning on the Horizon (2016) (0)
Abstract P350: Predicting the Restenosis Benefit of Drug-Eluting vs. Bare Metal Stenting Prior to Angiography: A Tool for Patients and Clinicians (2011) (0)
K10 and K6 Scales 2002 (2002) (0)
Abstract 39: Does Higher Use Of Non-invasive Testing Improve the Diagnostic Yield Of Coronary Angiography? (2013) (0)
Abstract 14912: Preventability of 30-Day Readmission After PCI (2013) (0)
Hospitals' Role In Readmissions. (2017) (0)
INTERNAL CARDIOVERTER DEFIBRILLATOR UTILIZATION IN THE COMMONWEALTH OF MASSACHUSETTS: 1997 TO 2008 (2011) (0)
Abstract P4: Does the Expected Reduction in Restenosis from Drug-Eluting Stents Predict Actual Use? An Assessment of Treatment-Risk Paradox Using the C-Statistic (2011) (0)
MEASURING PERFORMANCE FOR END-OF-LIFE CARE. (2021) (0)
Life Expectancy and Years of Potential Life Lost After Acute Myocardial Infarction by Sex and Race A Cohort-Based Study of Medicare Bene (2015) (0)
The Effect of Race-Ethnicity and Geography on the Comparative Effectiveness of Clozapine Among Medicaid Beneficiaries: (2013) (0)
Abstracts Translations (Chinese) (2015) (0)
Highlights Departments 2 Heart Disease 3 Primary Care 4 Clinical Decisionmaking 6 Outcomes / Effectiveness Research 7 Managed Care 9 Long-Term Care 10 Rural Health 10 Smoking Cessation (1999) (0)
Analysis of the lake couchiching data (1990) (0)
Abstract 13504: Mortality in STEMI Patients Undergoing Inter-Hospital Transfer for Primary PCI in Massachusetts (2010) (0)
Abstract 4: The Association Between Admission Rate and 30-Day Risk Standardized Readmission Rate for Heart Failure and Acute Myocardial Infarction (2011) (0)
PERIPHERAL Hospital Variation in Carotid Stenting Outcomes (2017) (0)
Abstract 19994: No Mortality Advantage of “On” versus “Off”-hours Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Results from the Massachusetts Data Analysis Center Registry (2010) (0)
TheEffectofRace-Ethnicityand GeographyonAdoptionofInnovations intheTreatmentofSchizophrenia (2012) (0)
Abstract 71: Causes of 30-day Readmission Rates after Percutaneous Coronary Intervention - Lessons from Direct Chart Review (2013) (0)
Treatment of Long- Term Psychiatric Disorders in the Managed Care Environment (1998) (0)
A Network Representation of the Multiprocess Dynamic Linear Model (1992) (0)
Use of clozapine and antipsychotic polypharmacy among patients with schizophrenia: Characterizing the prescribers (2015) (0)
Abstract 17725: Growth in Non-Emergency PCI at Hospitals Without Surgery-On-Site Since the Completion of the MASS COMM Trial - A Comparison of the MASS COMM RCT and Cohort Study (2013) (0)
DEVELOPMENTS IN ACUTE MYOCARDIAL INFARCTION MORTALITY IN THE UNITED STATES: CHANGES IN RISK-STANDARDIZED MORTALITY RATES FROM 1995 TO 2008 (2011) (0)
Nonparametric Analysis of Immune System MNarkers in the HIV Epidemic . Was there a change in the AIDS epidemic in 1987 ? (2008) (0)
Abstract 8: Hospice Use Following Implantable Cardioverter-Defibrillation Implantation in Older Patients: Results from the NCDR (2016) (0)
SOCIOECONOMIC STATUS MODIFIES THE EFFECT OF RACE ON LIFE EXPECTANCY AFTER ACUTE MYOCARDIAL INFARCTION (2015) (0)
Abstract 10: Hospital-Quality Following Percutaneous Coronary Intervention In Massachusetts: Experience From 2003-2008 (2011) (0)
Understanding the large heterogeneity in hospital readmissions and mortality for acute myocardial infarction. (2020) (0)
Abstract 345: High Risk Characteristics of Patients Returning Within 30 Days After PCI with Chest Discomfort (2014) (0)
Effect of Parity Legislation on Substance Abuse Treatment (2007) (0)
Abstract 147: Do Billing Data Accurately Describe Causes Of Readmission After PCI? An Analysis Of A Large PCI Readmission Database. (2014) (0)
Force on Performance Measures of the American College of Cardiology Foundation/American Heart Association Task ACCF/AHA New Insights Into the Methodology of Performance Measurement : A Report (2013) (0)
1135-68 Sex differences in invasive cardiac procedures in the elderly: 1993–1999 (2004) (0)
Statistical Approaches for Quantifying the Quality of Neurosurgical Care. (2022) (0)
1040-76 30-day mortality trends following acute myocardial infarction in the elderly (2004) (0)
On Assessing the Quality of Health Care Providers Using Time-Varying Patient Outcomes (2018) (0)
A Bayesian hierarchical model for characterizing the diffusion of new antipsychotic drugs (2020) (0)
Impact of early surveillance on safety signal identification in the CathPCI DELTA study (2020) (0)
Evaluation of the Hospital Readmissions Reduction Program (2019) (0)
Abstract 2: Life Expectancy and Years of Life Lost by Patients Admitted to High and Low Performing Hospitals (2015) (0)
Hospital Mortality in Acute Myocardial Infarction—Reply (2010) (0)
Abstract 19066: Quantifying the Years of Life Gained From Myocardial Infarction Admission Process-of-Care Measures (2014) (0)
Abstract 4600: Long-Term Clinical Outcomes Following Drug-eluting and Bare Metal Stenting in Patients With Chronic Kidney Disease in Massachusetts (2009) (0)
Abstract 158: Geographic and Temporal Variation in Implanted Cardiac Devices to Treat Heart Failure (2016) (0)
Combining randomized trial data to estimate heterogeneous treatment effects (2015) (0)
Abstract 24: Outcomes of Single and Dual Chamber ICDs for Primary Prevention of Sudden Cardiac Death (2012) (0)
Analytical strategies to reduce Readers guide to critical appraisal of cohort (2005) (0)
Outcomes/Epidemiology/Socioeconomics (2015) (0)
AS-36: Independent U.S. Validation of the British Columbia Percutaneous Coronary Intervention Risk Score (2010) (0)
Response to letters regarding article, "Bayesian methods affirm the use of percutaneous coronary intervention to improve survival in patients with unprotected left main coronary artery disease". (2014) (0)
Identification of ESRD in Cardiovascular Procedural Databases (2019) (0)
Regularization and Hierarchical Prior Distributions for Adjustment with Health Care Claims Data: Rethinking Comorbidity Scores (2017) (0)
Abstract P108: Assessing Utility of Drug-Eluting Stents in Coronary Patients Aged 85 Years and Older (2011) (0)
BIVALIRUDIN THERAPY IS ASSOCIATED WITH IMPROVED CLINICAL AND ECONOMIC OUTCOMES IN STEMI PATIENTS UNDERGOING PCI: RESULTS FROM AN OBSERVATIONAL DATABASE (2010) (0)
Abstract 344: Interoperator Variability and Physician Learning with Medical Devices: Experience with Three New Vascular Closure Devices (2013) (0)
Continuing medical education program in the journal of hospital medicine. (2010) (0)
Multiple outcomes and multiple sources of evidence: best statistical practices. (2011) (0)
Abstract 14: Regional Cardiologist Density and 30-Day and 1-Year Mortality in Acute Myocardial Infarction and Heart Failure (2013) (0)
Abstract 9351: Are “All-Comer” Clinical Trials Representative of Contemporary Clinical Practice: A Linked Analysis of the Dual Antiplatelet Therapy (DAPT) Study and the National Cardiovascular Data Registry® (2013) (0)
Epidemiologic Studies of Medical Devices (2019) (0)
Abstract 14804: Acute and 3-year Bleeding Risks: Comparing Drug-Eluting to Bare-Metal Stents in Old and Very Old Adults in a Community Population (2010) (0)
Abstract 319: Hospital Variation in Carotid Artery Stenting Outcomes: An NCDR® Analysis (2013) (0)
Not Sold on Performance Measures (2008) (0)
Abstract 367: Comparison of the Healthcare Systems of the United States and Portugal: Epidemiology and Management of Coronary Heart Disease (2014) (0)
Regional Density Of Cardiologists And Mortality For Acute Myocardial Infarction And Heart Failure (2017) (0)
EFFECTS OF REGIONAL MEDICARE ADVANTAGE PENETRATION ON RISK-STANDARDIZED OUTCOME MEASURES (2011) (0)
Hospital Mortality in Acute Myocardial Infarction. Authors' reply (2010) (0)
Abstract 16239: Association Between Coronary Arterial Dominance and Mortality in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention (2012) (0)
TheEffectofRace-Ethnicityonthe ComparativeEffectivenessofClozapine AmongMedicaidBeneficiaries (2013) (0)
LINKING THE NCDR CATHPCI REGISTRY WITH ADMINISTRATIVE CLAIMS TO DETERMINE ATTRIBUTION OF REPEAT REVASCULARIZATION FOLLOWING INDEX DRUG-ELUTING STENT IMPLANTATION (2019) (0)
Abstract 13: Risks of Death and Hospital Readmission by Time Following Hospitalization for Heart Failure and Acute Myocardial Infarction (2013) (0)
Factors Associated With Off-Label Utilization of Second-Generation Antipsychotics Among Publicly Insured Adults. (2021) (0)
Abstracts From the Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Conference 2009 1 Incorporation of a Covariate for "Compassionate Use" into Risk-Adjusted Modeling of Mortality after Percutaneous Coronary Interventions (2009) (0)
1-27-2012 Statistical Issues in Assessing Hospital Performance (2014) (0)
VASCULAR CLOSURE DEVICE FAILURE AND VASCULAR COMPLICATIONS IN CONTEMPORARY PRACTICE (2011) (0)
Abstract 17587: Coronary Artery Bypass Graft: Heart Surgery Center Performance in Contemporary China (2010) (0)
Behavioral Health Parity: Consequences for Federal Employee Health Plans (2007) (0)

This paper list is powered by the following services:

Other Resources About Sharon-Lise Normand

en.wikipedia.org

What Schools Are Affiliated With Sharon-Lise Normand?

Sharon-Lise Normand is affiliated with the following schools: